Embedded in the genomes of all vertebrates are the proviral remnants of previous retroviral infections. Although the overwhelming majority has suffered inactivating mutations, current research suggests that members of one family of human retroelements may still be capable of movement.
The vast majority of endogenous retroviruses are inactive. Most species have a few proviruses with replicative potential, however, and of these, a handful are associated with spontaneous tumours. Humans have appeared to be one exception to this generalization, and it is widely believed that none of our complement of proviruses is replication competent. Very recently, however, a few tantalizing clues suggesting the presence of potentially active human endogenous retroviruses (HERVs) have been published. In particular, one study published recently in Current Biology [2] has demonstrated the presence of a very recently acquired, apparently intact HERV in a small fraction of the human population.
Endogenous retroviruses have been found in all vertebrate species examined to date and constitute a significant fraction of the genome. In general, the number of proviruses found in a given species is roughly proportional to the effort expended in searching for them. From studies in humans [3] , pigs [4] and mice [1] we can infer that each species has a limited number of retrovirus groups (perhaps up to thirty). Each group will have undergone amplification independently and full-length proviruses are present in copy numbers ranging from one to a thousand or more, with perhaps ten to a hundred times more solo LTRs. Members of a given group will show a relatively high degree of sequence conservation, whereas a much lower degree of homology is shown between different groups. Each provirus is randomly integrated in the genome and the likelihood that two independent integrations occur at the same position is essentially negligible. Each provirus can therefore be identified via its host flanking sequences. This makes it relatively trivial to design PCR assays that will distinguish the presence or absence of a given provirus, thereby allowing studies of proviral inheritance.
Proviral inheritance might have numerous consequences for the host. Some stem from the insertion of multiple copies of DNA sequences containing signals capable of modifying transcription or RNA processing. Thus proviruses might act to cause chromosomal rearrangement by homologous recombination, as a source of novel control sequences for cellular genes or as insertional mutagens. Alternatively, there might be consequences from viral gene expression, with either pathogenic [1] or possibly beneficial effects [5] . In the extreme case, transcription may lead to virus activation and the formation of virally induced tumours, as has been well documented with certain endogenous murine leukemia viruses and mouse mammary tumour viruses [1] .
It was this latter possibility that initially fueled the search for HERVs with replicative potential. Later studies have been greatly facilitated by the progress of the human genome project. Collectively, HERVs comprise approximately 7% of the human genome [6, 7] . Three classes of HERV have been identified: class I HERVs (2.3% of the genome) are similar to exogenous gamma-retroviruses such as murine leukemia virus; class II HERVs (0.7%) are related to beta-retroviruses such as mouse mammary tumour virus; and class III HERVs (4%) are distantly related to spumaretroviruses. Despite their number, to date no replicationcompetent HERVs have been identified.
For a number of years the HERV-K(HML-2) group has looked the most likely to provide an active virus [8] . Currently, there are 30-50 relatively intact HERV-K(HML-2) proviruses, and around 1000 solo LTRs in the human genome. One or more proviruses belonging to this group are responsible for the production of virus-like particles from human teratocarcinoma cells. Initial analyses of the coding potential of cloned proviruses from this group, by sequencing or coupled in vitro transcription-translation assays, did not identify any intact proviruses. With one exception, all carried mutations interrupting one or more of the viral genes [9, 10] . The one exception, a provirus mapped to human chromosome 7, carried a single point mutation in the pol gene, substituting cysteine for tyrosine in a highly conserved YXDD motif of the protein product [11] . The number of mutations is very low, however, contrasting significantly with the highly mutated state of almost all other HERVs, where multiple frameshifts litter the proviral genome [3] . This suggests that the HERV-K(HML-2) proviruses studied have entered the human genome relatively recently. This is consistent with the fact that many of these proviruses are not present in our closest primate neighbours [9, 12] . This does not appear to be the end of the story, however. Very recent reports from two groups now indicate a degree of polymorphism in the human population, and have identified two apparently intact proviruses. One study [13] focussed on the chromosome 7 provirus and showed that two out of seven individuals carry proviruses without the inactivating tyrosine-to-cysteine mutation. The second study [2] identified two novel proviruses that are polymorphic in humans with allele frequencies of 4 and 19%. Characterization of these proviruses revealed that one had identical LTRs and complete open reading frames for all the viral proteins. Both these studies reveal one potential drawback of relying on a single sequenced allele as representative of the human genome.
The identity of the LTRs and the presence of open reading frames, coupled with the fact that these proviruses have not become fixed in the human population, suggest that these proviruses might have formed within the last 200,000 years. If so, is it possible that reintegrations are continuing to occur, either in the germ line or in somatic tissues? One approach to this question is to look for the potential for movement -to test whether the proviruses identified can yield infectious virus following DNA transfection. One potential problem with this approach will be to find the right cells -a number of retroviruses will only grow on an extremely limited set of cells. In addition, inapparent mutations in non-coding sequences may be present.
Alternatively, one could carry out a detailed search for novel integrations in different human populations or tumour tissues. Unfortunately, the PCR approaches used in the experiments described above will not be suitable for such investigations since they require knowledge of the proviral flanking sequence. Rather, high-resolution Southern blotting approaches, using strategies designed to maximize the resolution of multicopy retroviral families [14] should be employed. Preliminary studies have confirmed the potential of this approach (J. Fitzpatrick and J. M. Coffin, personal communication). Such studies might yet suggest that endogenous retroviruses can provide a genetic basis for some human diseases.
Endogenous retroviruses show a significant tendency to recombine. Figure 1 illustrates a variety of different recombination products that have been documented. They include: homologous recombination between the viral LTRs, resulting in solo LTRs [15] ; recombination between two different proviruses, leading to substantial deletions or rearrangements of cellular DNA [16] between the 3′ and 5′ LTRs of allelic proviruses, resulting in a tandemly duplicated provirus [13, 17] ; and gene conversion events which occur at a surprisingly high frequency [18] . There is, however, no mechanism for the precise excision of a provirus (except by gene conversion with another copy of the same region that never had a provirus).
A shared provirus in two species thus implies a common ancestor. One such provirus present in gorillas and chimpanzees, but not present in humans, provides evidence that some fraction of the former two species are more closely related to one another than to humans, even though the gorilla lineage diverged before separation of humans and chimps [19] . A second manifestation of the use of endogenous retroviruses in evolutionary studies is the use of sequence comparisons between the two LTRs of a provirus, identical at the time of integration, as molecular clocks. Phylogenetic analyses of tree structures involving both LTRs will readily reveal gene conversion events which will often escape detection in analyses involving single insert sequences, skewing estimates of mutation rates [18] .
Although the HERV-K(HML-2) group still shows signs of movement, evolutionary studies show clearly that this group is of considerable antiquity. A number of proviruses are present at the same locations in humans and Old World monkeys, implying that these elements first entered the primate germ line over 35 million years ago [12, 20] . How has the ability to generate novel integrants been preserved in the face of continued random mutagenesis? Conservative estimates suggest that the rate of mutation is around 0.2% per million years [18] , a rate which would be expected to inactivate proviruses quite rapidly. Analyses of HERV-K(HML-2) LTRs formed at different times during evolution are consistent with the sequential appearance of a series of active proviruses, each seeding a novel burst of increase in provirus copy number [12, 20] .
How are these active proviruses formed? Given the high rates of gene conversion observed between HERVs it is tempting to speculate that recombination between proviruses at different chromosomal locations plays an important role in maintaining the endogenous life style, perhaps as important as recombination during reverse transcription for defective retroviruses [1] . The combination of random mutagenesis leading to alterations in proviral expression, together with gene conversion and/or recombination during reverse transcription to reverse inactivating mutations in coding sequences, might allow continued low level generation of novel proviruses capable of reintegration, thereby permitting survival of integrated retroviruses in the germ line.
